Drugs / CD 40
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT00020670 | Feb 2001 → Apr 2003 | leukemia | Dana-Farber Cancer Institute | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD 40 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00020670 ↗ |